View More Recent Stories

Dec 26, 2024 11:32PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX

Dec 25, 2024 11:32PM ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX

Dec 24, 2024 04:09PM ROSEN, A TOP-RANKED LAW FIRM, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX

Dec 23, 2024 02:40PM KYTX Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against Kyverna Therapeutics, Inc. (KYTX)

Dec 23, 2024 06:03AM KYTX INVESTOR ALERT: Kyverna Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

Dec 22, 2024 05:12PM ROSEN, NATIONAL TRIAL LAWYERS, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX

Dec 22, 2024 08:33AM Faruqi & Faruqi Reminds Kyverna Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 7, 2025 - KYTX

Dec 21, 2024 04:10PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX

Dec 20, 2024 04:35PM ROSEN, LEADING TRIAL ATTORNEYS, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX

Dec 19, 2024 04:35PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX

Dec 19, 2024 11:00AM KYTX INVESTORS: Kirby McInerney LLP Reminds Kyverna Therapeutics, Inc. of Important Deadline and Encourages Investors to Contact the Firm

Dec 18, 2024 04:29PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX

Dec 17, 2024 11:45AM KYTX INVESTOR NOTICE: Kyverna Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Dec 17, 2024 11:31AM SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics

Dec 16, 2024 07:12PM ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX

Dec 15, 2024 07:07PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX

Dec 14, 2024 07:06PM ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX

Dec 13, 2024 07:06PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX

Dec 13, 2024 04:06PM Kyverna Therapeutics (KYTX) Strengthens Leadership Team

Dec 12, 2024 06:10PM ROSEN, A LEADING NATIONAL FIRM, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX

Dec 12, 2024 04:01PM KYTX LAWSUIT ALERT: Kyverna Therapeutics Investors Should Contact Block & Leviton to Learn How They Might Recover Losses

Dec 11, 2024 06:04PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX

Nov 20, 2024 06:46AM Kyverna Therapeutics Inc (KYTX) PT Lowered to $6 at H.C. Wainwright

Nov 14, 2024 10:02AM Kyverna Therapeutics (KYTX) Announces New Patient Data Highlighting Potential of KYV-101

Nov 13, 2024 04:30PM Kyverna Therapeutics (KYTX) Announces Resignation of Chief Medical Officer

Oct 21, 2024 08:01AM Kyverna Therapeutics (KYTX) Appoints Mert Aktar to its Board

Oct 17, 2024 06:44AM JPMorgan on Kyverna Therapeutics Inc (KYTX): 'armed with compelling clinical evidence to-date'

Oct 10, 2024 03:52AM UBS Starts Kyverna Therapeutics Inc (KYTX) at Buy

Sep 30, 2024 08:30AM JPMorgan refreshed its U.S. Analyst Focus List, adding these six stocks

Sep 25, 2024 11:00AM JPM just refreshed its US Analyst Focus List, adding these 5 stocks

Sep 19, 2024 06:47AM H.C. Wainwright Reiterates Neutral Rating on Kyverna Therapeutics Inc (KYTX)

Sep 17, 2024 02:00PM JPMorgan refreshed its U.S. Analyst Focus List and added these four names

Sep 16, 2024 08:04AM Kyverna Therapeutics (KYTX) Announces Leadership Update

Aug 15, 2024 06:41AM Kyverna Therapeutics Inc (KYTX) PT Lowered to $7 at H.C. Wainwright

Aug 12, 2024 04:05PM Kyverna Therapeutics (KYTX) Receives U.S. FDA RMAT Designation for KYV-101 in the Treatment of Patients With Progressive Myasthenia Gravis

Jul 16, 2024 10:54AM H.C. Wainwright Reiterates Neutral Rating on Kyverna Therapeutics Inc (KYTX)

Jun 20, 2024 08:55AM Kyverna Therapeutics (KYTX) Receives U.S. FDA IND Clearance for KYV-101

May 13, 2024 06:00PM Sell-off in this biopharma stock is 'overdone' says JPMorgan

View More Recent Stories